Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases 3U01AR078544-05S1
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury
Recipient
Not specified
Award Amount
$147,015.00
Ceiling
$147,015.00
Awarded
August 30, 2024
Identifier
3U01AR078544-05S1
NIH NIAMS awarded a research project to optimize novel molecular target-based drugs for arsenical skin injury, including drug formulation and testing.
Description
Research funding for the development and testing of small molecule drugs targeting arsenical skin injury. The project involves drug formulation, efficacy testing in animal models, and clinical translation.